Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion

Cancer Immunol Immunother. 2021 Oct;70(10):3057-3059. doi: 10.1007/s00262-021-03023-1.

Fei Wang^{1

2}, Li Yang¹, Qun Gao^{1

3}, Lan Huang¹, Liping Wang³, Jing Wang⁴, Shengdian Wang⁵, Bin Zhang⁶, Yi Zhang^{7

8

9}

¹ Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, China.
² School of Life Sciences, Zhengzhou University, No. 100 Kexue Road, Zhengzhou, 450001, Henan Province, China.
³ Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, China.
⁴ Department of Respiration, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, China.
⁵ Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
⁶ Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
⁷ Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, China. [email protected].
⁸ School of Life Sciences, Zhengzhou University, No. 100 Kexue Road, Zhengzhou, 450001, Henan Province, China. [email protected].
⁹ Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, China. [email protected].

No abstract available

Publication types